NeuroViOme:用于研究神经退行性疾病的病毒或feome集合
Benjamin Weller1, Chung-Wen Lin2, Simin Rothballer2
1Institute of Network Biology (INET), Molecular Targets and Therapeutics Center, Helmholtz Center Munich, German Research Center for Environmental Health, Munich- Neuherberg, Germany. benjamin.weller@helmholtz-munich.de.
Journal of neurovirology
|March 2, 2026
概括
神经退行性疾病可能与病毒感染有关. 一个新的资源,NeuroViOme,对病毒蛋白进行了分类,以研究这些相互作用,并推进神经退行研究.
科学领域:
- 神经科学是一个神经科学.
- 病毒学 病毒学
- 基因组学就是基因组学.
背景情况:
- 像ALS和MS这样的神经退行性疾病对全球健康构成重大挑战,治疗选择有限.
- 新兴研究表明,病毒感染可能通过直接影响或免疫反应引发或恶化神经退行.
- 了解病毒宿主蛋白相互作用对于神经退行性疾病研究至关重要,但缺乏系统研究.
研究的目的:
- 为神经退行症研究建立一个全面的病毒性开放阅读框架 (ORF) 资源.
- 促进在神经退行性疾病中病毒蛋白与宿主细胞相互作用的系统调查.
- 为互动组映射和神经退行症中的功能基因组学研究提供基础.
主要方法:
- 从9个选定的病毒中编制了一个全面的病毒开放阅读框架 (ORF) 集合.
- 根据患病率,神经向性和与神经退行性疾病 (ALS,MS,阿尔茨海默氏病,帕金森病) 的联系来选择病毒.
- 包括来自肠道病毒,疹病毒,HERV-K和JCPyV的ORF.
主要成果:
- 开发了NeuroViOme,这是一种新的资源,几乎包含了九种相关病毒的所有蛋白质编码序列.
- NeuroViOme是迄今为止为神经退行症研究组装的最广泛的病毒ORF集.
- 该资源可以对病毒蛋白相互作用及其对宿主通路的影响进行系统研究.
结论:
- NeuroViOme提供了一个基础资源,用于研究病毒对神经退行症的贡献.
- 该资源将加速对神经疾病中的病毒病原和宿主细胞干扰的研究.
- 允许未来的互动组映射和功能基因组学揭示ALS和MS中的机制.
相关概念视频
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Viruses with RNA Genomes
1.1K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.1K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Proteomics
10.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
10.0K


